You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 9, March 1, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serological Response to Syphilis Treatment

A New Analysis of Old Data

Stuart T. Brown, MD; Akbar Zaidi, MS; Sandra A. Larsen, PhD; Gladys H. Reynolds, PhD

JAMA. 1985;253(9):1296-1299.


Abstract

One important aspect of the posttreatment evaluation of patients with early syphilis is assessment of serological test results. Using information previously collected from 818 patients in the Early Syphilis Study, we evaluated the seroresponse of people treated for primary or secondary syphilis. We generated curves describing the VDRL titer declines with time. The VDRL titer declined approximately fourfold at three months and eightfold at six months. These observations will allow clinicians to identify treatment failures or reinfections at the earliest possible time during their follow-up.

(JAMA 1985;253:1296-1299)



Author Affiliations

From the Division of Sexually Transmitted Diseases, Center for Prevention Services (Drs Brown and Reynolds and Mr Zaidi); and the Sexually Transmitted Diseases Laboratory Program, Center for Infectious Diseases (Dr Larsen), Centers for Disease Control, Atlanta.


Footnotes

Reprint requests to Technical Information Services, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333 (Dr Brown).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK
Warwick et al.
Int J STD AIDS 2009;20:229-230.
ABSTRACT | FULL TEXT  

Reactivity in the Venereal Diseases Research Laboratory test and the Mercia(R) IgM enzyme immunoassay after treatment of early syphilis
McMillan and Young
Int J STD AIDS 2008;19:689-693.
ABSTRACT | FULL TEXT  

Primary syphilis
Eccleston et al.
Int J STD AIDS 2008;19:145-151.
ABSTRACT | FULL TEXT  

Syphilis
Lewis and Young
Sex. Transm. Infect. 2006;82:iv13-iv15.
FULL TEXT  

Azithromycin versus Penicillin G Benzathine for Early Syphilis
Holmes
NEJM 2005;353:1291-1293.
FULL TEXT  

A Decline in C6 Antibody Titer Occurs in Successfully Treated Patients with Culture-Confirmed Early Localized or Early Disseminated Lyme Borreliosis
Philipp et al.
CVI 2005;12:1069-1074.
ABSTRACT | FULL TEXT  

Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features
Singh and Romanowski
Clin. Microbiol. Rev. 1999;12:187-209.
ABSTRACT | FULL TEXT  

A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection
Rolfs et al.
NEJM 1997;337:307-314.
ABSTRACT | FULL TEXT  

Serologic Response to Treatment of Syphilis in Patients With HIV Infection
Yinnon et al.
Arch Intern Med 1996;156:321-325.
ABSTRACT  

The Response of Symptomatic Neurosyphilis to High-Dose Intravenous Penicillin G in Patients with Human Immunodeficiency Virus Infection
Gordon et al.
NEJM 1994;331:1469-1473.
ABSTRACT | FULL TEXT  

Serologic Response to Treatment of Infectious Syphilis
Romanowski et al.
ANN INTERN MED 1991;114:1005-1009.
ABSTRACT  

Serologic Testing after Therapy for Syphilis: Is There a Test for Cure?
Lukehart
ANN INTERN MED 1991;114:1057-1058.
ABSTRACT  

Sexually Transmitted Diseases
Albrecht and Wilkes
Journal of Pharmacy Practice 1991;4:237-246.
 

Effect of Human Immunodeficiency Virus (HIV) Infection on the Course of Syphilis and on the Response to Treatment
Musher et al.
ANN INTERN MED 1990;113:872-881.
ABSTRACT  

Extensive Nodular Secondary Syphilis
Sapra and Weatherhead
Arch Dermatol 1989;125:1666-1669.
ABSTRACT  

From the MMWR: Morbidity and Mortality Report Centers for Disease Control, Atlanta
Arch Dermatol 1989;125:15-16.
ABSTRACT  

Failure of Erythromycin to Cure Secondary Syphilis in a Patient Infected With the Human Immunodeficiency Virus
Duncan
Arch Dermatol 1989;125:82-84.
ABSTRACT  

Recommendations for Diagnosing and Treating Syphilis in HIV-Infected Patients
JAMA 1988;260:2488-2489.
 

Treatment of Primary and Secondary Syphilis: Defining Failure at Three- and Six-Month Follow-up
Guinan
JAMA 1987;257:359-360.
ABSTRACT  

Diagnostic Decision: Syphilis Tests in Diagnostic and Therapeutic Decision Making
HART
ANN INTERN MED 1986;104:368-376.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.